DexCom Inc. Stock Underperforms Monday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.DexCom Inc. (DXCM) shares fell 1.39% to $91.06 on Monday, snapping a four-day winning streak and closing 1.62% below its 52-week high of $92.56. The stock underperformed compared to competitors like Abbott Laboratories, which rose slightly, while Insulet Corp. declined more sharply. Trading volume was below the 50-day average. This mixed performance occurred during a broader market session where the Dow Jones rose and the S&P 500 fell.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DexCom Inc. (DXCM) slid 1.39% to $91.06 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.26% to 53,417.16 and the S&P 500 Index falling 0.28% to 7,652.86.
The stock's fall snapped a four-day winning streak.
DexCom Inc. closed 1.62% short of its 52-week high of $92.56, which the company reached on August 21st.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Abbott Laboratories (ABT) rose 0.03% to $116.67 and Insulet Corp. (PODD) fell 1.85% to $145.42.
Trading volume (4.4 M) remained 710,964 below its 50-day average volume of 5.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-24-26 1655ET